Spencer and Davie: Dynamic histone acetylation and its involvement in transcriptionMarmorstein R and Roth SY (2001) Histone acetyltransferases:function, structure, and catalysis. Curr Opin <strong>Gene</strong>t Dev 11,155-161.Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, andKouzarides T (2000) Regulation of E2F1 activity byacetylation. EMBO J 19, 662-671.Moore SC and Ausio J (1997) Major role of the histones H3-H4in the folding of the chromatin fiber. Biochem Biophys ResCommun 230, 136-139.Munshi N, Merika M, Yie J, Senger K, Chen G, and Thanos D(1998) Acetylation of HMG I(Y) by CBP turns off IFN-βexpression by disrupting the enhanceosome. Mol Cell 2,457-467.Myers FA, Evans DR, Clayton AL, Thorne AW, and Crane-Robinson C (2001) Targeted and extended acetylation ofhistones H4 and H3 at active and inactive genes in chickenembryo erythrocytes. J Biol Chem 276, 20197-20205.Norton VG, Imai BS, Yau P, and Bradbury EM (1989) Histoneacetylation reduces nucleosome core particle linking numberchange. Cell 57, 449-457.Orphanides G and Reinberg D (2000) RNA polymerase IIelongation through chromatin. Nature 407, 471-475.Palaparti A, Baratz A, and Stifani S (1997) TheGroucho/transducin-like enhancer of split transcriptionalrepressors interact with the genetically defined aminoterminalsilencing domain of histone H3. J Biol Chem 272,26604-26610.Parekh BS and Maniatis T (1999) Virus infection leads tolocalized hyperacetylation of histones H3 and H4 at the IFNβpromoter. Mol Cell 3, 125-129.Polesskaya A, Duquet A, Naguibneva I, Weise C, Vervisch A,Bengal E, Hucho F, Robin P, and Harel-Bellan A (2000)CREB-binding protein/p300 activates MyoD by acetylation.J Biol Chem 275, 34359-34364.Protacio RU, Li G, Lowary PT, and Widom J (2000) Effects ofhistone tail domains on the rate of transcriptional elongationthrough a nucleosome. Mol Cell Biol 20, 8866-8878.Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, SchmidM, Opravil S, Mechtler K, Ponting CP, Allis CD, andJenuwein T (2000) Regulation of chromatin structure by sitespecifichistone H3 methyltransferases. Nature 406, 593-599.Reid JL., Iyer VR, Brown PO, and Struhl K (2000) Coordinateregulation of yeast ribosomal protein genes is associated withtargeted recruitment of Esa1 histone acetylase. Mol Cell 6,1297-1307.Ridsdale JA, Hendzel MJ, Delcuve GP, and Davie JR (1990)Histone acetylation alters the capacity of the H1 histones tocondense transcriptionally active/competent chromatin. JBiol Chem 265, 5150-5156.Rundlett SE, Carmen AA, Suka N, Turner BM, and Grunstein M(1998) Transcriptional repression by UME6 involvesdeacetylation of lysine 5 of histone H4 by RPD3. Nature392, 831-835.Schaufele F, Enwright JF, Wang X, Teoh C, Srihari R, EricksonR, MacDougald OA, and Day RN (2001) CCAAT/EnhancerBinding Protein alpha Assembles Essential CooperatingFactors in Common Subnuclear Domains. Mol Endocrinol15, 1665-1676.Schwarz PM, Felthauser A, Fletcher TM, and Hansen JC (1996)Reversible oligonucleosome self-association: dependence ondivalent cations and core histone tail domains. Biochemistry35, 4009-4015.Seigneurin-Berny D, Verdel A, Curtet S, Lemercier C, Garin J,Rousseaux S, and Khochbin S (2001) Identification ofComponents of the Murine Histone Deacetylase 6 Complex:Link between Acetylation and Ubiquitination SignalingPathways. Mol Cell Biol 21, 8035-8044.Sewack GF, Ellis TW, and Hansen U (2001) Binding of TATAbinding protein to a naturally positioned nucleosome isfacilitated by histone acetylation. Mol Cell Biol 21, 1404-1415.Shang Y, Hu X, DiRenzo J, Lazar MA, and Brown M ( 2000)Cofactor dynamics and sufficiency in estrogen receptorregulatedtranscription. Cell 103, 843-852.Singh H, Sekinger EA, and Gross DS (2000) Chromatin andcancer: causes and consequences. J Cell Biochem Suppl 35,61-68.Smith ER, Allis CD, and Lucchesi JC (2001) Linking globalhistone acetylation to the transcription enhancement of X-chromosomal genes in Drosophila males. J Biol Chem 276,31483-31486.Spencer VA and Davie JR (1999) Role of covalent modificationsof histones in regulating gene expression. <strong>Gene</strong> 240, 1-12.Spencer VA and Davie JR (2001) Dynamically acetylatedhistone association with transcriptionally active andcompetent genes in the avian adult β-globin gene domain. JBiol Chem 276, 34810-34815.Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL,O'Malley BW, and Mancini MA (2001) FRAP reveals thatmobility of oestrogen receptor-α is ligand- and proteasomedependent.Nat Cell Biol 3, 15-23.Sterner DE and Berger SL (2000) Acetylation of histones andtranscription-related factors. Microbiol Mol Biol Rev 64,435-459.Strahl BD and Allis CD (2000) The language of covalent histonemodifications. Nature 403, 41-45.Strahl BD, Ohba R, Cook RG, and Allis CD (1999) Methylationof histone H3 at lysine 4 is highly conserved and correlateswith transcriptionally active nuclei in Tetrahymena. ProcNatl Acad Sci USA 96, 14967-14972.Sun JM, Chen HY, and Davie JR (2001) Effect of Estradiol onhistone acetylation dynamics in human breast cancer cells. JBiol Chem 276, 49435-49442.Sun JM, Chen HY, Moniwa M, Samuel S, and Davie JR (1999)Purification and characterization of chicken erythrocytehistone deacetylase 1. Biochemistry 38, 5939-5947.Tazi J and Bird A (1990) Alternative chromatin structure at CpGislands. Cell 60, 909-920.Tse C and Hansen JC (1997) Hybrid trypsinized nucleosomalarrays: identification of multiple functional roles of theH2A/H2B and H3/H4 N-termini in chromatin fibercompaction. Biochemistry 36, 11381-11388.Tse C, Sera T, Wolffe AP, and Hansen JC (1998) Disruption ofhigher-order folding by core histone acetylation dramaticallyenhances transcription of nucleosomal arrays by RNApolymerase III. Mol Cell Biol 18, 4629-4638.Turner BM (1991) Histone acetylation and control of geneexpression. J Cell Sci 99 ( Pt 1), 13-20.Turner BM (1998) Histone acetylation as an epigeneticdeterminant of long-term transcriptional competence. CellMol Life Sci 54, 21-31.Turner BM (2000) Histone acetylation and an epigenetic code.Bioessays 22, 836-845.12
<strong>Gene</strong> <strong>Therapy</strong> and <strong>Molecular</strong> <strong>Biology</strong> Vol 7, page 13Turner BM, Birley AJ, and Lavender J (1992) Histone H4isoforms acetylated at specific lysine residues defineindividual chromosomes and chromatin domains inDrosophila polytene nuclei. Cell 69, 375-384.Vandel L and Trouche D (2001) Physical association betweenthe histone acetyl transferase CBP and a histone methyltransferase. EMBO Rep 2, 21-26.Verschure PJ, van Der Kraan, I, Manders EM, and van Driel R(1999) Spatial relationship between transcription sites andchromosome territories. J Cell Biol 147, 13-24.Vogelauer M, Wu J, Suka N, and Grunstein M (2000) Globalhistone acetylation and deacetylation in yeast. Nature 408,495-498.Walia H, Chen HY, Sun JM, Holth LT, and Davie JR (1998)Histone acetylation is required to maintain the unfoldednucleosome structure associated with transcribing DNA. JBiol Chem 273, 14516-14522.Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT,Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S,Hopp T, Fuqua SA, Lopez GN, Kushner PJ, and Pestell RG(2001). Direct acetylation of the estrogen receptor α hingeregion by p300 regulates transactivation and hormonesensitivity. J Biol Chem 276, 18375-18383.Wang X, Moore SC, Laszckzak M, and Ausio J (2000)Acetylation increases the α-helical content of the histonetails of the nucleosome. J Biol Chem 275, 35013-35020.Watson AD, Edmondson DG, Bone JR, Mukai Y, Yu Y, Du W,Stillman DJ, and Roth SY (2000) Ssn6-Tup1 interacts withclass I histone deacetylases required for repression. <strong>Gene</strong>sDev 14, 2737-2744.Winston F and Allis CD (1999) The bromodomain: a chromatintargetingmodule? Nat Struct Biol 6, 601-604.Wittschieben BO, Fellows J, Du W, Stillman DJ, and SvejstrupJQ (2000) Overlapping roles for the histone acetyltransferaseactivities of SAGA and elongator in vivo. EMBO J 19,3060-3068.Wittschieben BO, Otero G, de Bizemont T, Fellows J,Erdjument-Bromage H, Ohba R, Li Y, Allis CD, Tempst P,and Svejstrup JQ (1999) A novel histone acetyltransferase isan integral subunit of elongating RNA polymerase IIholoenzyme. Mol Cell 4, 123-128.Zhang DE and Nelson DA (1988b) Histone acetylation inchicken erythrocytes. Rates of acetylation and evidence thathistones in both active and potentially active chromatin arerapidly modified. Biochem J 250, 233-240.Zhang DE and Nelson DA (1988a) Histone acetylation inchicken erythrocytes. Rates of deacetylation in immature andmature red blood cells. Biochem J 250, 241-245.Zhang W and Bieker JJ (1998) Acetylation and modulation oferythroid Kruppel-like factor (EKLF) activity by interactionwith histone acetyltransferases. Proc Natl Acad Sci USA 95,9855-9860.Zhang W, Bone JR, Edmondson DG, Turner BM, and Roth SY(1998) Essential and redundant functions of histoneacetylation revealed by mutation of target lysines and loss ofthe Gcn5p acetyltransferase. EMBO J 17, 3155-3167.Zhang WH, Srihari R, Day RN, and Schaufele F (2001)CCAAT/enhancer-binding protein alpha alters histone H3acetylation at large subnuclear domains. J Biol Chem 276,40373-40376.Zhou X, Marks PA, Rifkind RA, and Richon VM (2001) Cloningand characterization of a histone deacetylase, HDAC9. ProcNatl Acad Sci USA 98, 10572-10577.Zlatanova J, Leuba SH, and van Holde K (1998) Chromatin fiberstructure: morphology, molecular determinants, structuraltransitions. Biophys J 74, 2554-2566.Virginia A. Spencer and James R. Davie13
- Page 7 and 8: Instructions to authors:Gene Therap
- Page 9: Please submit an electronic version
- Page 12: 103-111 ResearchArticle113-133 Revi
- Page 17 and 18: Gene Therapy and Molecular Biology
- Page 19 and 20: Gene Therapy and Molecular Biology
- Page 21 and 22: Gene Therapy and Molecular Biology
- Page 23 and 24: Gene Therapy and Molecular Biology
- Page 25: Gene Therapy and Molecular Biology
- Page 29 and 30: Gene Therapy and Molecular Biology
- Page 31 and 32: Gene Therapy and Molecular Biology
- Page 33 and 34: Gene Therapy and Molecular Biology
- Page 35 and 36: Gene Therapy and Molecular Biology
- Page 37 and 38: Gene Therapy and Molecular Biology
- Page 39 and 40: Gene Therapy and Molecular Biology
- Page 41 and 42: Gene Therapy and Molecular Biology
- Page 43 and 44: Gene Therapy and Molecular Biology
- Page 45 and 46: Gene Therapy and Molecular Biology
- Page 47 and 48: Gene Therapy and Molecular Biology
- Page 49 and 50: Gene Therapy and Molecular Biology
- Page 51 and 52: Gene Therapy and Molecular Biology
- Page 53 and 54: Gene Therapy and Molecular Biology
- Page 55 and 56: Gene Therapy and Molecular Biology
- Page 57 and 58: Gene Therapy and Molecular Biology
- Page 59 and 60: Gene Therapy and Molecular Biology
- Page 61 and 62: Gene Therapy and Molecular Biology
- Page 63 and 64: Gene Therapy and Molecular Biology
- Page 65 and 66: Gene Therapy and Molecular Biology
- Page 67 and 68: Gene Therapy and Molecular Biology
- Page 69 and 70: Gene Therapy and Molecular Biology
- Page 71 and 72: Gene Therapy and Molecular Biology
- Page 73 and 74: Gene Therapy and Molecular Biology
- Page 75 and 76: Gene Therapy and Molecular Biology
- Page 77:
Gene Therapy and Molecular Biology
- Page 80 and 81:
Epperly et al: Late injection of Mn
- Page 82 and 83:
Epperly et al: Late injection of Mn
- Page 84 and 85:
Goldberg-Cohen et al: Regulation of
- Page 86 and 87:
Goldberg-Cohen et al: Regulation of
- Page 88 and 89:
Goldberg-Cohen et al: Regulation of
- Page 90 and 91:
Gascón-Irún et al: Gene therapy a
- Page 92 and 93:
Gascón-Irún et al: Gene therapy a
- Page 94 and 95:
Gascón-Irún et al: Gene therapy a
- Page 96 and 97:
Gascón-Irún et al: Gene therapy a
- Page 98 and 99:
Gascón-Irún et al: Gene therapy a
- Page 100 and 101:
Gascón-Irún et al: Gene therapy a
- Page 102 and 103:
Gascón-Irún et al: Gene therapy a
- Page 104 and 105:
Gascón-Irún et al: Gene therapy a
- Page 106 and 107:
Suzuki et al: Regulation of the Sp/
- Page 108 and 109:
Suzuki et al: Regulation of the Sp/
- Page 110 and 111:
Suzuki et al: Regulation of the Sp/
- Page 112 and 113:
Suzuki et al: Regulation of the Sp/
- Page 114 and 115:
Li et al: MET amplification in live
- Page 116 and 117:
Li et al: MET amplification in live
- Page 118 and 119:
Chavakis et al: Leukocyte adhesion
- Page 120 and 121:
Chavakis et al: Leukocyte adhesion
- Page 122 and 123:
Chavakis et al: Leukocyte adhesion
- Page 124 and 125:
Chavakis et al: Leukocyte adhesion
- Page 126 and 127:
Chavakis et al: Leukocyte adhesion
- Page 128 and 129:
Sanlioglu et al: Adenovirus mediate
- Page 130 and 131:
Sanlioglu et al: Adenovirus mediate
- Page 132 and 133:
Sanlioglu et al: Adenovirus mediate
- Page 134 and 135:
Sanlioglu et al: Adenovirus mediate
- Page 136 and 137:
Sanlioglu et al: Adenovirus mediate
- Page 138 and 139:
Sanlioglu et al: Adenovirus mediate
- Page 140 and 141:
Sanlioglu et al: Adenovirus mediate
- Page 142 and 143:
Sanlioglu et al: Adenovirus mediate
- Page 144 and 145:
Sanlioglu et al: Adenovirus mediate
- Page 146 and 147:
Sanlioglu et al: Adenovirus mediate
- Page 148 and 149:
Sanlioglu et al: Adenovirus mediate
- Page 150 and 151:
George et al: Gene therapy for vasc
- Page 152 and 153:
George et al: Gene therapy for vasc
- Page 154 and 155:
George et al: Gene therapy for vasc
- Page 156 and 157:
George et al: Gene therapy for vasc
- Page 158 and 159:
George et al: Gene therapy for vasc
- Page 160 and 161:
George et al: Gene therapy for vasc
- Page 162 and 163:
George et al: Gene therapy for vasc
- Page 164 and 165:
George et al: Gene therapy for vasc
- Page 166 and 167:
George et al: Gene therapy for vasc
- Page 168 and 169:
Zhang et al: Angiogenic Gene Therap
- Page 170 and 171:
Zhang et al: Angiogenic Gene Therap
- Page 172 and 173:
Zhang et al: Angiogenic Gene Therap
- Page 174 and 175:
Zhang et al: Angiogenic Gene Therap
- Page 176 and 177:
Zhang et al: Angiogenic Gene Therap
- Page 178 and 179:
Zhang et al: Angiogenic Gene Therap
- Page 180 and 181:
Zhang et al: Angiogenic Gene Therap
- Page 182 and 183:
Xu et al: G-CSF receptor-mediated S
- Page 184 and 185:
Xu et al: G-CSF receptor-mediated S
- Page 186 and 187:
Xu et al: G-CSF receptor-mediated S
- Page 188 and 189:
Burek et al: Calcium induced cell d
- Page 190 and 191:
Burek et al: Calcium induced cell d
- Page 192 and 193:
Burek et al: Calcium induced cell d
- Page 194 and 195:
Burek et al: Calcium induced cell d
- Page 196 and 197:
David et al: Current status and fut
- Page 198 and 199:
David et al: Current status and fut
- Page 200 and 201:
David et al: Current status and fut
- Page 202 and 203:
David et al: Current status and fut
- Page 204 and 205:
David et al: Current status and fut
- Page 206 and 207:
David et al: Current status and fut
- Page 208 and 209:
David et al: Current status and fut
- Page 210 and 211:
David et al: Current status and fut
- Page 212 and 213:
David et al: Current status and fut
- Page 214 and 215:
David et al: Current status and fut
- Page 216 and 217:
David et al: Current status and fut
- Page 218 and 219:
David et al: Current status and fut
- Page 220 and 221:
David et al: Current status and fut
- Page 222 and 223:
David et al: Current status and fut
- Page 224 and 225:
David et al: Current status and fut
- Page 226 and 227:
Stoll et al: The role of EBV and ge
- Page 228 and 229:
Stoll et al: The role of EBV and ge
- Page 230 and 231:
Stoll et al: The role of EBV and ge
- Page 232 and 233:
Stoll et al: The role of EBV and ge
- Page 234 and 235:
Stoll et al: The role of EBV and ge
- Page 236 and 237:
Maruyama et al: Kidney-targeted pla
- Page 238 and 239:
Maruyama et al: Kidney-targeted pla
- Page 240 and 241:
Maruyama et al: Kidney-targeted pla
- Page 242 and 243:
Maruyama et al: Kidney-targeted pla
- Page 244 and 245:
Kren et al: Hepatocyte-targeted del
- Page 246 and 247:
Kren et al: Hepatocyte-targeted del
- Page 248 and 249:
Kren et al: Hepatocyte-targeted del
- Page 250 and 251:
Kren et al: Hepatocyte-targeted del
- Page 252 and 253:
Kren et al: Hepatocyte-targeted del
- Page 254 and 255:
Zeng: PRL-3 as a target for cancer
- Page 256 and 257:
Zeng: PRL-3 as a target for cancer
- Page 258 and 259:
Zeng: PRL-3 as a target for cancer
- Page 260 and 261:
Latchman: Protective effect of heat
- Page 262 and 263:
Latchman: Protective effect of heat
- Page 264 and 265:
Latchman: Protective effect of heat
- Page 266 and 267:
Latchman: Protective effect of heat
- Page 268 and 269:
Latchman: Protective effect of heat
- Page 270 and 271:
Cai et al: Lung cancer gene therapy
- Page 272 and 273:
Cai et al: Lung cancer gene therapy
- Page 274 and 275:
Cai et al: Lung cancer gene therapy
- Page 276 and 277:
Cai et al: Lung cancer gene therapy
- Page 278 and 279:
Cai et al: Lung cancer gene therapy
- Page 280:
Cai et al: Lung cancer gene therapy
- Page 283 and 284:
Gene Therapy and Molecular Biology
- Page 285 and 286:
Gene Therapy and Molecular Biology
- Page 287 and 288:
Gene Therapy and Molecular Biology
- Page 289 and 290:
Gene Therapy and Molecular Biology
- Page 291 and 292:
Gene Therapy and Molecular Biology
- Page 293 and 294:
Gene Therapy and Molecular Biology
- Page 295 and 296:
Gene Therapy and Molecular Biology
- Page 297 and 298:
Gene Therapy and Molecular Biology
- Page 299 and 300:
Gene Therapy and Molecular Biology
- Page 301 and 302:
Gene Therapy and Molecular Biology
- Page 303 and 304:
Gene Therapy and Molecular Biology
- Page 305 and 306:
Gene Therapy and Molecular Biology
- Page 307 and 308:
Gene Therapy and Molecular Biology
- Page 309:
Gene Therapy and Molecular Biology